Back

Epidemiological insights into heart failure: prevalence, incidence, and mortality rates in the population of Slovakia

12 May 2024 (16:00 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome 5 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Peter Lesny

Comenius University Hospital, Bratislava (Slovakia)

7 More presentations in this session

Presentation thumbnail
Comprehensive characterization of patients with heart failure and recovered ejection fraction: insights from a real-world population from a regional hospital in Portugal
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
The prognostic role of mean platelet volume in chronic decompensated heart failure.
Miss A. Catana (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Predictors of quality of life in heart failure patients
Doctor K. Bince (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
The incidence of severe heart failure among hospitalized patients with HFrEF. Do we have a simplified diagnostic criteria helping in the earlier diagnosis and better prognosis?
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Prevalence and incidence of dilated cardiomyopathy in the United States, France, Germany, Italy, Spain, and the United Kingdom: a systematic literature review
Doctor A. Berge (Canonsburg, US)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome 5

The Event

Event poster

Heart Failure 2024

12 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of heart failure patients in the Czech Republic. A population-based study
thumbnail
Congress Presentation
Epidemiology of heart failure
thumbnail
Congress Presentation
The epidemiology of heart failure in Hungary: basic data and temporal trends from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources